The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets

American Journal of Gastroenterology

Volumn 94, Issue 9, 1999, Pages 2408-2411

  Chen, Chiung Yu ^b   Shiesh, Shu Chu ^b   Wu, Ming Che ^b   Lin, Xi Zhang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CIPROFLOXACIN;

ANIMAL MODEL; ARTICLE; BILE; BILE DUCT OBSTRUCTION; BILE DUCT PRESSURE; BILE SECRETION; CHOLANGITIS; DRUG BLOOD LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; BILE; BILE DUCTS; CHOLESTASIS; CIPROFLOXACIN; FEMALE; MALE; SWINE;

EID: 0033198553     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01365.x     Document Type: Article

References (17)

1. Mortimer PR, Mackie DB, Haynes S. Ampicillin levels in human bile in the presence of biliary tract disease. Br Med J 1969:3:88-9.
2. Thomas M. Antibiotics in bile. J Antimicrob Chemother 1983; 12:419-22.
3. LeBel M. Ciprofloxacin: Chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 1988;8:3-33.
4. Sung JJY, Lyon DJ, Roamy S, et al. Intravenous ciprofloxacin as treatments for patients with acute suppurative cholangitis: A randomized, controlled clinical trial. J Antimicrob Chemother 1995:35:855-64.
5. Leung JWC, Ling TKW, Chan RCY, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994;40: 716-21.
6. Ball CS, Mansons JM, Ried F, et al. The pharmacokinetics of the biliary excretion of ciprofloxacin. HPB Surg 1989;1:31927.
7. van den Hazel SJ, de Vries XH, Speelman P, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996:40:265860.
8. Csendes A, Sepulveda A, Burdiles P, et al. Common bile duct pressure in patients with common bile duct stones with or without acute suppurative cholangitis. Arch Surg 1988;123: 697-9.
9. Koechlin C, Linger FJL, Monteil H. High-performance liquid chromatography for the determination of the three new fluoroquinolones: Fleroxacin, temafloxacin and A-64370, in biological fluids. J Chromatogr 1989;491:379-87.
10. Thompson JE Jr, Pitt HA, Doty JE, et al. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet 1990;171:275.
11. Gartung C, Ananthanarayanan M, Rahman MA, et al. Down regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996:110:199-209.
12. Dumont M, Jacquemin E, D'Hont C, et al. Expression of the liver Na+-independent orgainic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 1997; 27:1051-6.
13. Huang T, Bass JA, Williams RD. The significance of biliary pressure in cholangitis. Arch Surg 1969;98:629-32.
14. Leung JWC, Chan RCY, Cheung SW, et al. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 1990:25:399-406.
15. Leung JWC, Chan CY, Lai CW, et al. Effect of biliary obstruction on the hepatic excretion of Imipenem-Cilastatin. Antimicrob Agents Chemother 1992:36:2057-60.
16. Keighley MR, Drysdale RB, Quoraishi AH, et al. Antibiotics in biliary tract disease: The relative importance of antibiotic concentration in the bile and serum. Gut 1976; 17:495-500.
17. Scott-Conner CEH, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994:57:316-36.